梅波利祖马布在严重喘中有效性与/没有慢性鼻炎与鼻息肉:现实世界的聚合分析
Florence Schleich1, Stelios Loukides2, Rekha Chaudhuri3
1GIGA I3, Respiratory Medicine, Exercise Physiology Laboratory, University of Liège, Liège, Belgium.
Allergy
|July 1, 2025
概括
梅波利祖马布有效地减少了带有eosinophilic表型 (SAEP) 的严重喘和带有鼻息肉的慢性鼻炎 (CRSwNP) 的恶化. 治疗改善了结局,不管是基线血中乙氨基酸细胞计数或并发性CRSwNP.
科学领域:
- 肺部病理学 肺部病理学
- 过敏和免疫学 过敏和免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 带有eosinophilic表型 (SAEP) 的严重喘和带有鼻息肉的慢性鼻炎 (CRSwNP) 是2型驱动的炎症性疾病.
- 这些情况共享潜在的乙酸性炎症,并具有显著的疾病负担.
- 梅波利祖马布 (Mepolizumab) 是一种干白素-5抑制剂,是SAEP和CRSwNP的批准治疗方法.
研究的目的:
- 为了评估mepolizumab在患有并发性SAEP和CRSwNP的患者中的实际有效性.
- 为了比较梅波利祖马布对SAEP单独治疗的患者和并发性CRSwNP患者的恶化和其他结果的影响.
主要方法:
- 汇集了来自五个欧洲队列的数据,其中包括1037名SAEP成年患者.
- 患者被分为没有CRSwNP的SAEP (SAEP[-]CRSwNP) 和具有CRSwNP的SAEP (SAEP[+]CRSwNP).
- 评估了临床显著恶化 (CSEs) 的发生率,口服皮质类固醇的使用,血液中异氨基酸细胞计数 (BEC),肺功能和喘控制测试 (ACT) 在开始梅波利祖马布前后的得分.
主要成果:
- 梅波利祖马布在12个月后显著降低了SAEP[-]CRSwNP的72.7%和SAEP[+]CRSwNP的79.7%的CSE年率.
- 患有并发性CRSwNP的患者在CSE的减少率比没有CRSwNP的患者大30.0%.
- 在两组中都观察到口服皮质类固醇使用,BEC,肺功能和ACT得分的改善; 47.2%和52.3%的患者实现了临床缓解标准.
结论:
- 梅波利祖马布在改善SAEP患者的喘结果方面表现出显著的有效性.
- 梅波利祖马布的益处是显而易见的,不论是血中异氨基细胞的基线数量还是并发性CRSwNP的存在.
- 现实世界的数据支持mepolizumab作为一种有价值的治疗选择,用于管理复杂的eosinophilic气道疾病.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
476
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
476
Drugs Used in Lower Respiratory Disorders: Overview
618
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
618
Antiasthma Drugs: Leukotriene Modifiers
495
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
495
Inhaled Medications
407
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
407
COPD: Management Using Bronchodilators and Corticosteroids
324
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
324
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
399
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
399


